Quetiapine augmentation of treatment-resistant depression: a comparison with lithium.

Author: Des RosiersJoël, DoréeJean-Pierre, ElieRobert, GendronAlain, LewViviane, StipEmmanuel, TourjmanS Valérie

Paper Details 
Original Abstract of the Article :
OBJECTIVE: The prevalence of and morbidity associated with treatment-resistant depression has motivated the exploration of treatment alternatives. In this study, quetiapine was compared with lithium in the augmentation of treatment-resistant depression. RESEARCH DESIGN AND METHODS: Open-label, comp...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1185/030079906X162809

データ提供:米国国立医学図書館(NLM)

Quetiapine: A New Oasis in the Desert of Treatment-Resistant Depression

Treatment-resistant depression (TRD) can be a formidable challenge, with many patients struggling to find effective therapies. This research explores the efficacy of quetiapine as an augmentation agent in TRD, comparing its effectiveness to lithium. The study aims to provide a comparative analysis of quetiapine and lithium in augmenting existing antidepressant treatments in patients with TRD.

Quetiapine: A Potential Game-Changer for TRD

The study, conducted on 20 patients with TRD, demonstrated a significant improvement in depression symptoms in both quetiapine and lithium groups. However, quetiapine showed a greater improvement in depression severity compared to lithium, particularly in the later stages of treatment. These findings suggest that quetiapine may be a more effective augmentation agent for TRD.

Finding Hope in the Desert of TRD

This research offers a glimmer of hope for individuals struggling with TRD. The study's findings suggest that quetiapine could provide a more effective treatment option for this challenging condition. However, remember, treatment for TRD is highly individualized. It's crucial to work closely with a healthcare professional to determine the most effective treatment for your specific needs.

Dr. Camel's Conclusion

This research is like a camel caravan exploring a new oasis in the vast desert of TRD. Quetiapine shows promise as a potential solution, offering a more effective path to healing. However, as with any oasis, further exploration and careful navigation are needed to maximize its benefits.

Date :
  1. Date Completed 2007-03-15
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

17288688

DOI: Digital Object Identifier

10.1185/030079906X162809

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.